Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases
about
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3GHuman APOBEC1 cytidine deaminase edits HBV DNACloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editingTranscriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRsC-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzymeHuman RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducibleInduction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbitsP63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndromeARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editingInhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexesSecondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loopComplete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in miceTargeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48Molecular characterization of the 5' regulatory region of rat sodium-dependent multivitamin transporter gene.Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity.NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in FaslDiabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammationGenetic Architectures of Quantitative Variation in RNA Editing PathwaysRNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cellsTwo distinct TATA-less promoters direct tissue-specific expression of the rat apo-B editing catalytic polypeptide 1 gene.Expression of multiple glutamate transporter splice variants in the rodent testis.APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.Housekeeping promoter 5'pcmah-2 of pig CMP-N-acetylneuraminic acid hydroxylase gene for NeuGc expression.The 5'-flanking region of the rat GABA(A) receptor alpha2-subunit gene (Gabra2).Non-redundancy of cytidine deaminases in class switch recombination.Absence of APOBEC-1 mediated mRNA editing in human carcinomas.Genetic Markers for Coronary Artery Disease
P2860
Q21146408-245264E1-4106-47EB-B842-272F836932E7Q21245048-EF31F8F7-503F-4294-BBB1-51B978681736Q24313466-1642DB4B-21A5-4EBE-9FB4-581C95791DA2Q24618983-0598A360-871E-46A2-9F59-0A60C9109B48Q24633130-BFA5CE1C-EC92-4802-901D-9A187444AE1DQ24670551-B20FA8DC-D691-4425-8B80-1D14A39F5D82Q27312336-E057D7C6-E15B-4F91-8955-E84705DE43DEQ28190562-5C9E78C0-BFA3-420B-93D7-1B8504FCDB20Q28204149-003FCEF8-1811-4630-8A3A-D3B9F0C58D4AQ28286991-B5816455-4A77-47A8-9270-76D4179E9C21Q28289196-8291AE2E-A3AD-49CF-B235-AAD9631A3EB7Q28291031-0A09EE5C-6326-40C4-BBB3-BF66566F75DCQ28301468-F7DDA6B9-FF15-4611-95EE-CC06D5EDCD12Q28594252-03184E50-D185-49FC-9A48-D5385E17376BQ31919395-A493048D-7864-4D4D-9822-ED6280834DB6Q33587739-3F7E465D-07FC-4B20-B471-5D6D1D6167F6Q34366223-86E36199-233B-4A1D-9B49-0537FAA777C2Q35120769-47BDA8B4-74AF-4A86-9259-98C77FF5EC10Q36399625-8BDF2B79-654D-48D7-A2B4-02C611ABA78BQ36658372-3A0709A3-8B6D-41E0-882E-1AE00124B9EBQ36677357-BF66303E-1AE9-498C-BFA0-B07006929A11Q36689901-83449695-5689-4DF3-B7BB-4E7FCE634FC4Q36870312-70070067-6DA8-404C-814A-04A14BC5742AQ37084378-2D804692-4EC2-4692-AAA6-6BD34CD4D39AQ37685643-898DFD93-A026-4C20-9B78-43DB2ACD0073Q38172884-52C006B3-85C9-4B67-A83F-A99D787B908DQ38199065-D09DDEB4-0893-4BF1-954C-B6F68E2B294DQ40481554-62E9C300-1560-4DA2-A168-B63C0E3C2DADQ40671232-8C74AEA8-F4D9-4D36-8C6E-63038E0E456AQ40700876-6F721CBD-F217-4969-BA39-45DE3CF7093DQ44781044-395BAC40-7D4C-4152-9A3F-FECF793FE36CQ53415994-2DD21A95-7364-4D7A-BCA1-D72052C0CEC9Q57825461-392E339D-283A-40DD-8496-5C6D97D7D911
P2860
Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Alternative mRNA splicing and ...... cleoside/nucleotide deaminases
@en
type
label
Alternative mRNA splicing and ...... cleoside/nucleotide deaminases
@en
prefLabel
Alternative mRNA splicing and ...... cleoside/nucleotide deaminases
@en
P2093
P2860
P356
P1476
Alternative mRNA splicing and ...... cleoside/nucleotide deaminases
@en
P2093
J Krushkal
K Kobayashi
M Nakamuta
M Yamamoto
P2860
P304
13042-13056
P356
10.1074/JBC.270.22.13042
P407
P577
1995-06-01T00:00:00Z